Publication Name	World Journal of Diabetes
Manuscript ID	67273
Country	Greece

Received	2021-04-20 09:14
Peer-Review Started	2021-04-20 09:16
First Decision by Editorial Office Director	2021-06-05 02:36
Return for Revision	2021-06-05 02:36
Revised	2021-06-30 20:12
Publication Fee Transferred
Second Decision by Editor	2021-12-24 04:48
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2021-12-25 20:13
Articles in Press	2021-12-25 20:13
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-01-05 13:06
Publish the Manuscript Online	2022-01-11 06:48

ISSN	1948-9358 (online)
Open Access
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review
Manuscript Source	Invited Manuscript
All Author List	Sarantis Livadas, Panagiotis Anagnostis, Julia K Bosdou, Dimitra Bantouna and Rodis Paparodis
Funding Agency and Grant Number
Corresponding Author	Sarantis Livadas, MD, PhD, Consultant Physician-Scientist, Endocrine Unit, Athens Medical Centre, M. Geroulanou 15, Athens 10563, Greece. sarntis@gmail.com
Key Words	polycystic ovary syndrome; PCOS; diabetes; insulin resistance; dysglycemia
Core Tip	Polycystic ovary syndrome (PCOS) often coexists with a wide spectrum of dysglycemic conditions, ranging from impaired glucose tolerance to type 2 diabetes mellitus (T2D), which occur to a greater extent compared to healthy body mass index-matched women. This review provides the most current knowledge on the different aspects of T2D in women with PCOS, including epidemiology, common pathophysiologic mechanisms, and methodology employed for dysglycemia assessment, as well as to scrutinize the risk factors for T2D development and to suggests the optimal management of these women in the context of T2D risk reduction.
Publish Date	2022-01-11 06:48
Citation	Doğruel H, Aydemir M, Balci MK. Management of diabetic foot ulcers and the challenging points: An endocrine view. World J Diabetes 2022; 13(1): 5-26
URL	https://www.wjgnet.com/1948-9358/full/v13/i1/5.htm
DOI	https://dx.doi.org/10.4239/wjd.v13.i1.5

Full Article (PDF)	WJD-13-5.pdf
Full Article (Word)	WJD-13-5.docx